These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 14767719)

  • 21. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Frutiger K; Lukas TJ; Gorrie G; Ajroud-Driss S; Siddique T
    Amyotroph Lateral Scler; 2008 Jun; 9(3):184-7. PubMed ID: 18574763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF levels in CSF and serum in mild ALS patients.
    Gao L; Zhou S; Cai H; Gong Z; Zang D
    J Neurol Sci; 2014 Nov; 346(1-2):216-20. PubMed ID: 25204587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered neuronal activities in the motor cortex with impaired motor performance in adult rats observed after infusion of cerebrospinal fluid from amyotrophic lateral sclerosis patients.
    Sankaranarayani R; Nalini A; Rao Laxmi T; Raju TR
    Behav Brain Res; 2010 Jan; 206(1):109-19. PubMed ID: 19747511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
    Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
    Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.
    Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR
    Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated cerebrospinal fluid and plasma homocysteine levels in ALS.
    Valentino F; Bivona G; Butera D; Paladino P; Fazzari M; Piccoli T; Ciaccio M; La Bella V
    Eur J Neurol; 2010 Jan; 17(1):84-9. PubMed ID: 19659753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
    Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS).
    Fang L; Huber-Abel F; Teuchert M; Hendrich C; Dorst J; Schattauer D; Zettlmeissel H; Wlaschek M; Scharffetter-Kochanek K; Tumani H; Ludolph AC; Brettschneider J
    J Neurol Sci; 2009 Oct; 285(1-2):62-6. PubMed ID: 19523650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Jiménez-Jiménez FJ; Hernánz A; Medina-Acebrón S; de Bustos F; Zurdo JM; Alonso H; Puertas I; Barcenilla B; Sayed Y; Cabrera-Valdivia F
    Acta Neurol Scand; 2005 Feb; 111(2):114-7. PubMed ID: 15644071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential diagnosis of amyotrophic lateral sclerosis from Guillain-Barré syndrome by quantitative determination of TDP-43 in cerebrospinal fluid.
    Hosokawa M; Arai T; Yamashita M; Tsuji H; Nonaka T; Masuda-Suzukake M; Tamaoka A; Hasegawa M; Akiyama H
    Int J Neurosci; 2014 May; 124(5):344-9. PubMed ID: 24066851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor.
    Sen I; Nalini A; Joshi NB; Joshi PG
    J Neurol Sci; 2005 Aug; 235(1-2):45-54. PubMed ID: 15936037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Shobha K; Vijayalakshmi K; Alladi PA; Nalini A; Sathyaprabha TN; Raju TR
    J Neurol Sci; 2007 Mar; 254(1-2):9-16. PubMed ID: 17254611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis.
    Gonçalves M; Tillack L; de Carvalho M; Pinto S; Conradt HS; Costa J
    Clin Chim Acta; 2015 Jan; 438():342-9. PubMed ID: 25261856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kaufmann E; Boehm BO; Süssmuth SD; Kientsch-Engel R; Sperfeld A; Ludolph AC; Tumani H
    Neurosci Lett; 2004 Nov; 371(2-3):226-9. PubMed ID: 15519762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis. Short communication.
    Matsuishi T; Nagamitsu S; Shoji H; Itoh M; Takashima S; Iwaki T; Shida N; Yamashita Y; Sakai T; Kato H
    J Neural Transm (Vienna); 1999; 106(9-10):943-8. PubMed ID: 10599876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in cerebrospinal fluid during elderly aging and in patients with sporadic form of amyotrophic lateral sclerosis.
    Isobe C; Abe T; Terayama Y
    Neurosignals; 2010; 18(1):43-8. PubMed ID: 20407287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis.
    Tortelli R; Copetti M; Ruggieri M; Cortese R; Capozzo R; Leo A; D'Errico E; Mastrapasqua M; Zoccolella S; Pellegrini F; Simone IL; Logroscino G
    Eur J Neurol; 2015 Jan; 22(1):215-8. PubMed ID: 24750431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
    Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
    Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.